<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190611043866N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-03-31</date_registration>
      <primary_sponsor>Birjand University of Medical Sciences</primary_sponsor>
      <public_title>The effect of mindfulness-based intervention on caregiver burden, perceived stress, and quality of life in family caregivers of patients with cancer</public_title>
      <acronym></acronym>
      <scientific_title>The effect of mindfulness-based intervention on caregiver burden, perceived stress, and quality of life in family caregivers of patients with cancer</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-03-03</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/40158</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: The study included two intervention and control groups (30 in each group). The intervention group received eight sessions of mindfulness program training for two hours and then completed the intervention Followed for two months. But during this time the control group does not receive any intervention, Randomization description: Referring to Iran-Mehr Hospital 60 family caregivers of patients with cancer are included in the study through available sampling. Then Samples were randomly divided into intervention and control groups, Respectively and one by one (each group 30).</study_design>
      <phase>N/A</phase>
      <hc_freetext>cancer.</hc_freetext>
      <i_freetext>Intervention 1: session 1,  goals  and  techniques included building a rapport with the client, obtaining information from the client, providing psycho-education on mindfulness, CBT, depression, and anxiety, identifying automatic thoughts and leading the client through a guided mindfulness meditation. session 2, goals and techniques included helping the client recognize that most of her thoughts are not facts, teaching the client to use the thought   record, educating client about cognitive distortion. session 3, goals and techniques included educating diaphragmatic breathing and sleep hygiene; next, teaching the client a brief body scan exercise to reduce muscle tension. session 4, goals and techniques included introducing mindful daily activity, teaching mindful eating and mindful labelling on  thoughts, feelings and behaviours. session 5, goals and techniques included introducing to enhancing recognition of personal consequences  of chronic worry, having the client perform a cost-benefit analysis of her  chronic worry, scheduling worry time and mindful worry-free zones. session 6, goals and techniques included generating a hierarchy of   worries, imaginary exposure with acceptance, incorporating in vivo exposure through increased participation in planned events. session 7,   goals and techniques included helping the client learn to identify and respond to early signs of relapse, collaborating with the client to generate responses to her early warning signs, helping the client practice developing a worry action plan. session 8, goals and techniques included reviewing the insights and techniques found most useful by the  client, identifying obstacles to practice mindfulness,  providing a checklist of the  techniques included in the program. Intervention 2: Control group: They do not receive any intervention.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No decision has been made for it</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zeinab Mehrizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 118, Taleghani Alley 17, Taleghani St, Esfarayen, North Khorasan Province.</address>
        <city>Esfarayen</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9661884915</zip>
        <telephone>+98 58 3723 4082</telephone>
        <email>zeinab.mehrizi@gmail.com</email>
        <affiliation>Birjand University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zeinab Mehrizi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 118, Taleghani Alley 17, Taleghani St, Esfarayen, North Khorasan Province.</address>
        <city>Esfarayen</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9661884915</zip>
        <telephone>+98 58 3723 4082</telephone>
        <email>zeinab.mehrizi@gmail.com</email>
        <affiliation>Birjand University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion Criteria for Cancer Patients: Being at least 18 years of age or older
having a cancer diagnosis approved by a specialist physician
undergoing cancer treatment
if the cancer treatment course is completed, more than four weeks after Do not end the treatment period
having a family caregiver who will take care of him at home
Inclusion criteria for caregivers: Women and men aged 18-75 years
able to read, write and speak Persian
play a key role in patient care
have a family relationship with the patient (spouse, child, parent or mother, sister or Brother, grandson, other relatives)
Willingness to participate in the program
lack of specific illness or unstable situation unable to care for a cancer patient
No cancer diagnosed in the past 4 years
No regular treatment by a psychologist or psychiatrist
Lack of self-reported diagnosis of mental disorders and cognitive impairment
Non-admission to psychiatric ward with diagnosis of psychiatric disorders in the past two years
No history of suicide
No treatment with anti psychotic and anti-convulsive drugs
No substance abuse or dependence in the past year
No recent recovery from substance abuse
Lack of previous or current participation in mindfulness programs and other psycho-social programs
Lack of do yoga and meditation exercises in the past year</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Having more than two sessions absent on schedule
Unwillingness or inability to continue participating in the study
Death of cancer patient during research
The occurrence of any physical or mental disorders that prevent the caregiving by the caregiver</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>session 1,  goals  and  techniques included building a rapport with the client, obtaining information from the client, providing psycho-education on mindfulness, CBT, depression, and anxiety, identifying automatic thoughts and leading the client through a guided mindfulness meditation. session 2, goals and techniques included helping the client recognize that most of her thoughts are not facts, teaching the client to use the thought   record, educating client about cognitive distortion. session 3, goals and techniques included educating diaphragmatic breathing and sleep hygiene; next, teaching the client a brief body scan exercise to reduce muscle tension. session 4, goals and techniques included introducing mindful daily activity, teaching mindful eating and mindful labelling on  thoughts, feelings and behaviours. session 5, goals and techniques included introducing to enhancing recognition of personal consequences  of chronic worry, having the client perform a cost-benefit analysis of her  chronic worry, scheduling worry time and mindful worry-free zones. session 6, goals and techniques included generating a hierarchy of   worries, imaginary exposure with acceptance, incorporating in vivo exposure through increased participation in planned events. session 7,   goals and techniques included helping the client learn to identify and respond to early signs of relapse, collaborating with the client to generate responses to her early warning signs, helping the client practice developing a worry action plan. session 8, goals and techniques included reviewing the insights and techniques found most useful by the  client, identifying obstacles to practice mindfulness,  providing a checklist of the  techniques included in the program.</i_keyword>
      <i_keyword>Control group: They do not receive any intervention.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Weitzner's Quality of Life Questionnaire score. Timepoint: Before and after the intervention and two months after the intervention. Method of measurement: weitzner's Quality of life questionnaire for caregivers of cancer patients.</prim_outcome>
      <prim_outcome>Cohen's perceived stress Questionnaire score. Timepoint: Before and after the intervention and two months after the intervention. Method of measurement: Cohen's perceived stress Questionnaire.</prim_outcome>
      <prim_outcome>Zarit's caregiver burden Questionnaire score. Timepoint: Before and after the intervention and two months after the intervention. Method of measurement: Zarit's caregiver burden Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Birjand University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-01-07</approval_date>
        <contact_name>Ethics Committee of Birjand University of Medical Sciences</contact_name>
        <contact_address>No. 118, Taleghani Alley 17,  Taleghani Ave, Esfarain, North Khorasan Province Birjand South Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
